PharmExec Blog

Merck to Close Eight Plants

KENILWORTH, NJ - MARCH 09: A car enters the em...
Image by Getty Images via @daylife

Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.”

Taking a page out of Pfizer’s book (Pfizer announced plans to cease production at eight of its global manufacturing sites in late May), Merck said it would try to make the transitions as painless as possible, working with local governments and other manufacturers to sell the plants in the hope of keeping workers employed. Still, Merck expects the worldwide cuts to total 15 percent of its work force by 2012.

Two of the sites being phased out are in the US, seven are in Europe, with the rest scattered from South America to Canada. Sixteen worldwide R&D labs were spared, and the company said it will continue to focus on cardiovascular, metabolic, and infectious disease areas, as well as four others.

Merck is also hoping to find annual savings of $3.5 billion by 2012. In addition to creating a flexible R&D organization, the company will also save $2.7 billion to $3.1 billion as a result of this restructuring.

Enhanced by Zemanta
This entry was posted in Strategy and tagged , , , , , , , . Bookmark the permalink. Trackbacks are closed, but you can post a comment.

3 Comments

  1. Natalie Audet
    Posted July 9, 2010 at 12:08 pm | Permalink

    Hi Natalie

    Do you remember about 1/1/2 years ago me saying to you Iheard a rummor the R& D was going to close in Merck Montreal ?
    Sometime rummors are correct!
    Best
    Ross

  2. Posted July 11, 2010 at 4:38 pm | Permalink

    Greetings Men and Women:

    May I ask, which Merck and Pfizer sites will be closed in the United States?

  3. m. Kranz
    Posted July 12, 2010 at 4:08 pm | Permalink

    With all the money we spend on their products, don’t you think that we deserve more R&D to help us battle all types of disease? Why cut costs when they are so profitable? World needs employers, especially ones that can advance our health.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Categories

  • Meta